We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.97B
AUM Growth
+$340M
Cap. Flow
+$192M
Cap. Flow %
3.86%
Top 10 Hldgs %
23.72%
Holding
1,286
New
328
Increased
312
Reduced
279
Closed
346

Sector Composition

Rank Sector Weight
1 Real Estate 12.54%
2 Energy 9.89%
3 Financials 8.72%
4 Industrials 6.89%
5 Consumer Discretionary 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRXL
901
DELISTED
Parexel International Corp
PRXL
$215K ﹤0.01%
3,980
-1,590
-29% -$81.5K
ARNA
902
DELISTED
Arena Pharmaceuticals Inc
ARNA
$214K ﹤0.01%
3,404
+41
+1% +$2.72K
ABAX
903
DELISTED
Abaxis Inc
ABAX
$214K ﹤0.01%
+5,500
New +$218K
ARIA
904
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$212K ﹤0.01%
26,310
-99,670
-79% -$776K
BIO icon
905
Bio-Rad Laboratories Class A
BIO
$8.42B
$211K ﹤0.01%
+1,650
New +$212K
ALGN icon
906
Align Technology
ALGN
$12B
$208K ﹤0.01%
4,020
NEOG icon
907
Neogen
NEOG
$2.05B
$208K ﹤0.01%
12,320
+480
+4% +$7.84K
CDMO
908
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$208K ﹤0.01%
+15,624
New +$206K
CTIC
909
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$208K ﹤0.01%
+6,110
New +$209K
ICUI icon
910
ICU Medical
ICUI
$3.93B
$207K ﹤0.01%
3,460
+90
+3% +$5.54K
TECH icon
911
Bio-Techne
TECH
$11.2B
$207K ﹤0.01%
9,720
-640
-6% -$14.4K
VIVO
912
DELISTED
Meridian Bioscience Inc
VIVO
$204K ﹤0.01%
+9,340
New +$214K
HOLX
913
DELISTED
Hologic
HOLX
$203K ﹤0.01%
9,420
-450
-5% -$9.71K
OMCL icon
914
Omnicell
OMCL
$1.86B
$203K ﹤0.01%
+7,100
New +$194K
MDCO
915
DELISTED
Medicines Co
MDCO
$203K ﹤0.01%
7,160
+1,330
+23% +$44K
HITK
916
DELISTED
HI-TECH PHARMACAL INC
HITK
$203K ﹤0.01%
+4,680
New +$203K
ARTC
917
DELISTED
ARTHROCARE CORP
ARTC
$202K ﹤0.01%
4,200
-230,801
-98% -$10.9M
QURE icon
918
uniQure
QURE
$2.68B
$201K ﹤0.01%
+12,882
New +$205K
ZLTQ
919
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$200K ﹤0.01%
+10,190
New +$199K
HMSY
920
CALL
DELISTED
HMS Holdings Corp.
HMSY
$191K ﹤0.01%
10,000
-5,000
-33% -$109K
SPPI
921
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$185K ﹤0.01%
23,660
-21,140
-47% -$179K
MNTA
922
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$175K ﹤0.01%
15,030
+4,440
+42% +$75.2K
REGI
923
DELISTED
Renewable Energy Group, Inc.
REGI
$171K ﹤0.01%
14,280
-31,280
-69% -$346K
BDSI
924
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$169K ﹤0.01%
+20,000
New +$161K
KOS icon
925
Kosmos Energy
KOS
$1.56B
$167K ﹤0.01%
+15,180
New +$163K

Similar funds

Weiss Multi-Strategy Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Weiss Multi-Strategy Advisers held 1,286 positions worth $4.97B, up 7.3% from $4.63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Weiss Multi-Strategy Advisers deployed $192M of net new capital in Q1 2014, opening 328 new positions and adding to 312 existing holdings. Its largest new stake was Hudson Pacific Properties: 335,714 shares worth $54.2M.

By sector, the portfolio is most concentrated in Real Estate at 13% of assets, down from 13% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Liberty Property Trust, an estimated $43.8M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q1 2014 buy was Hudson Pacific Properties: 335,714 shares worth $54.2M.
  • Weiss Multi-Strategy Advisers added most to LXP Industrial Trust in Q1 2014, an estimated $24.3M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2014 reduction was Liberty Property Trust, cutting an estimated $43.8M.
  • Weiss Multi-Strategy Advisers fully exited RETAIL PROPERTIES OF AMERICA, INC. in Q1 2014, selling an estimated $36.1M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 24% of its $4.97B portfolio in Q1 2014.
  • Weiss Multi-Strategy Advisers opened 328 new positions and closed 346 in Q1 2014.
  • Weiss Multi-Strategy Advisers's portfolio value rose 7.3% quarter-over-quarter to $4.97B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.